Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, October 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
EMD Millipore Launches OsteoMAX-XF™, a Fully-defined, Xeno-free Mesenchymal Stem Cell Osteogenic Differentiation Medium
Thursday, May 09, 2013
Enables rapid differentiation of fully functional human bone tissue from MSCs. More consistent and potent than currently available formulations . Accelerates time to mineralization to less than one week compared to the typical three weeks.

Merck Millipore Launches MILLIPLEX® MAP Kits
Tuesday, May 07, 2013
Enables detection of multiple pluripotency markers in a single measurement.

Ultra Compact 0.50ml Storage Tube
Friday, April 26, 2013
Octygen 0.50ml screw cap tube facilitates fast and simple sample handling.

Cellectricon Presents Transfection Solutions for Drug Discovery at Experimental Biology 2013
Friday, April 19, 2013
Advanced electroporation systems for primary and iPSC-derived cells.

Tecan Academy Offers On-Demand, Web-Based Training
Thursday, April 18, 2013
New web-based portal, Tecan Academy is convenient and affordable.

Effective Cryopreservation of iPS Cells
Thursday, April 04, 2013
STEM CELLBANKER® from AMSBIO is a chemically defined freezing medium with optimised formulation for stem cells and iPS cells storage as well as other valuable cells.

Safeware Quasar Exhibits at Chemspec Europe
Friday, March 29, 2013
Company will display its products in Munich from 5th to 6th June 2013.

Lonza Introduces Fresh Human Pancreatic Islets
Thursday, March 21, 2013
New Clonetics™ fresh human pancreatic islets used in a variety of research areas.

2D Coded Sample Storage StarterPacks
Tuesday, March 19, 2013
New 2013 Starterpacks ideal for smaller biobanks, biorepositories or biotech companies.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 483
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv